Neisseriaceae

Gonorrhea

Microbiology

Biology

Genitourinary system

Antibiotics

Neisseria gonorrhoeae

Internal medicine

Immunology

Human immunodeficiency virus (HIV)

Medicine

New England Journal of Medicine

Antibiotic-resistant Neisseria gonorrhoeae has prompted the development of new therapies. Zoliflodacin is a new antibiotic that inhibits DNA biosynthesis. In this multicenter, phase 2 trial, zoliflodacin was evaluated for the treatment of uncomplicated gonorrhea.

Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea